CDR1
Cerebellar degeneration-related antigen 1
Also known as: CDR1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for CDR1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
262 residues, UniProt reviewed canonical sequence.
>P51861|CDR1
1 MAWLEDVDFL EDVPLLEDIP LLEDVPLLED VPLLEDTSRL EDINLMEDMA LLEDVDLLED
61 TDFLEDLDFS EAMDLREDKD FLEDMDSLED MALLEDVDLL EDTDFLEDPD FLEAIDLRED
121 KDFLEDMDSL EDLEAIGRCG FSGRHGFFGR RRFSGRPKLS GRLGLLGRRG FSGRLGGYWK
181 TWIFWKTWIF WKTWIFRKTY IGWKTWIFSG RCGLTGRPGF GGRRRFFWKT LTDWKTWISF
241 WKTLIDWKTW ISFWKTLIDW KILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- 0.53
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- LED repeat
- WKTW repeat
- WKTW repeat
- LED repeat
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDR1 as an antibody target. Whether an autoantibody or antibody against CDR1 could matter depends on whether native CDR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDR1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...